Fig. 3From: Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trialsContent validation: key symptoms of GD reported by patients. GD Gaucher diseaseBack to article page